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PKD1 and PKD2 are the two genes responsible for the development of autosomal dominant polycystic 
kidney disease (ADPKD). PKD1 gene mutations accounts for ≈85% of all ADPKD cases, while the 
remaining ≈15% of cases is caused by mutations in the PKD2 gene. Genotyping for PKD1 and PKD2 
mutations was usually identified using conventional polymerase chain reaction (PCR) or PCR-single 
stranded conformation polymorphisms (SSCP) methods. In this study, we assessed the usefulness of 
eight common primers amplifying the respective genes in real-time high resolution melting analysis 
PCR (real-time HRMA PCR) in terms of time, cost and sensitivity with respect to PCR-SSCP method. We 
found that case sample can easily be differentiated from control sample by melting curve profile 
difference, although a primer was found to be less useful. We concluded that real-time HRMA PCR is a 
rapid and sensitive method to categorize samples based on the melting curve profiles with comparable 
sensitivity to conventional PCR-SSCP.  
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Autosomal dominant polycystic kidney disease (ADPKD) 
is one of the most common genetic renal diseases 




*Corresponding author. E-mail: patimahismail@gmail.com. Tel: 
03-89472314. Fax: 03- 89436178. 
 
Abbreviations: ADPKD, Autosomal dominant polycystic kidney 
disease; PCR, polymerase chain reaction; SSCP, single 
stranded conformation polymorphisms. 
(Torres and Harris, 2009). The disease is caused by 
mutations occurring in two known genes: PKD1 located 
on chromosome 16 (16p13.3) and PKD2 gene located on 
chromosome 4 (4q22). Both type 1 ADPKD and type 2 
are phenotypically similar with development of numerous 
cysts in both kidneys that may lead to end stage renal 
disease requiring dialysis in patients. However, type 1 
ADPKD is more severe in terms of age of diagnosis, 
prevalence of hypertension and age of end stage renal 
disease, requiring dialysis or renal transplantation. Most 
patients suffering from type 1 ADPKD experience renal 
failure  in  their  fifth  decade of life, while it is  delayed by  
  




Table 1. Primers used to amplify the PKD genes. 
 









(F) AAG GGT GGC AGA GGA GGT GA 
(R) CTA ATC GGC GGG GAG CTC TA 
120 61.0 74-84 
 




(F) GCA GCC TCA GTT GTG TTT CCT AAT C 
(R) AGT GCT GGG ATT ACA GGC ATG AAC C 
180 62.6 77-84 
Binczak et al., 
2006 
FF 
(F) CGT GCT GCT GCC CTA CGT C 
(R) CGT CCC CGA GCC ATT GTG 




(F) TTG AGT AGT TCC TGA AGC AGC 












(F) CCA TAC TAA CAC AAT GGA TAT AGC 
(R) CAG AAA CTC CAG CAG AGA CT 




(F) CCA AAA TCA TGT GAG CCA 
(R) GAG CAG CCA ACT GTA T 
210 58.7 75-84 
 




about two decades in patients with type 2 ADPKD 
(Schieren et al., 2006). 
The mutations in ADPKD are screened by using 
polymerase chain reaction (PCR) -based methodology. 
All the methods require the need of post PCR processing 
such as single stranded conformation polymorphisms 
(SSCP) and temperature gradient gel electrophoresis 
(TGGE). The basic of these methodology is to separate 
the DNA molecules  which differ by one or more 
nucleotides based on the size and the chemical or 
physical characteristics (Gasser et al., 2006). However, 
since gel electrophoresis is the only way to further 
analyse the amplicons, the techniques are relatively more 
laborious, and in need for rigid precautions to eliminate 
products crossover (Krypuy et al., 2006) and 
contamination that might happen when PCR products 
were exposed to the environment (Reed and Wittwer, 
2004) as well as a considerable technical skills required 
(Laurie and George, 2009). Moreover, not all mutations 
can be identified, thus selecting possible samples to 
which mutations are present is a challenge.  
High resolution melting analysis (HRMA) when 
combined with real-time PCR is proven to be a rapid 
technique for genotyping with a comparable sensitivity as 
the conventional methodology. In this study, we aimed to 
evaluate the usefulness of common primers that amplify 
PKD1 and PKD2 genes to be used for ADPKD samples 
genotyping from normal control sample using the real-
time HRMA analysis and to compare the advantages in 
contrast to PCR-SSCP.  
 
MATERIALS AND METHODS 
 
Samples and DNA extraction 
 
Buccal cells samples were collected from ADPKD patients and 
control subjects after obtaining the ethical clearance from 
respective organisations (Universiti Putra Malaysia (Reference 
number: UPM/FPSK/PADS/T7-MJKEtikaPer/F01(JSB_Okt03); 
Universiti Kebangsaan Malaysia (Reference number: 
UKM.1.5.3.5/244/SPP3).  A total of 16 buccal cells samples were 
recruited from the patients and control subjects. Each tube 
containing the samples was first washed thrice with 0.9% sodium 
chloride solution with 3:1 ratio. According to the manufacturer’s kit 
(Fermentas: Hanover, USA) protocol, genomic DNA was extracted 
and kept at -20°C. The concentration and purity of DNA was 
checked by using biophotometer (Eppendorf, Germany) against 
Tris-EDTA (TE) buffer as blank at 260 nm wavelength. 
 
 
Primers and PCR conditions 
 
Three sets of primers were used to amplify both PKD1 and PKD2 
gene, respectively (Table 1). The cycling optimizations for all 
primers were done in gradient PCR (Bio-Rad Thermal Cycler) using 
normal samples. A total volume of 25 µl PCR reaction was 
prepared in a single closed-tube containing 1x PCR buffer, 3.0 mM 
MgCl2 and 0.21 µM of each primer with 10 to 20 ng of genomic 
DNA. All primers had  an  initial  denaturation of 94°C for 4 to 6 min,  
  






Figure 1. PCR-SSCP result showing bands generated by 1, primer D16S291; 2, 
primer D4S423. The numbers of band are the same for control and case subject, 
and only different in the base size. All control samples regardless of primers had a 
slightly larger band size than the case samples, therefore migrated slower. The 
patterns of bands in the gel enabled the samples to be differentiated (a, control 





with a 30 cycles of denaturation, annealing with optimized 
temperature and extension; and final extension at 72°C for 10 to 20 
min (Table 1). 
 
 
Single-stranded conformation polymorphisms 
 
All samples were run in conventional PCR (Mastercycler, 
Eppendorf, Germany) prior to SSCP analysis. Electrophoresis were 
carried out in Origins (Elchrom Scientific, Cham, Switzerland) with 
voltage applied at 72 V (6 V per cm where cm = distance between 
electrodes) for up to 15 h. Following electrophoresis, the gels were 
stained with SYBR Green II. 
 
 
Real-time HRMA PCR 
 
For real-time PCR, each reaction tube was added 1 µl (20x) 
EvaGreen intercalating dye (Biotium, CA), to a total volume of 25 µl. 
The same cycling conditions were used in the Rotor-Gene 6000™ 
(Corbett Research, Mortlake, New South Wales, Australia) for real-
time HRMA with pre-amplification with additional five cycles. Melting 
temperatures were between 65 and 98°C and was raised at a rate 
of 0.1°C per second. The melt curve analysis was done by using 
the Rotor-Gene™ 6000 real-time rotary analyzer software. All 
samples and primers were run in duplicates for validation. A third 
blinded run for all primers were done by another person to further 
confirm the data obtained.  




ADPKD patients were diagnosed as having numerous 
cysts in both kidneys that were evidence during 
ultrasound with a mean age of 54.38 years. Control 
subjects were selected from healthy general population 
and were not related to the patients. They were matched 
by gender, age and race to the patients. The quantity of 
DNA is between 90 and 125 µg with purity reading at 





The PCR SSCP result showed several bands for control 
and case sample. Figure 1 shows the PCR SSCP result 
for primer D16S291 and primer D4S423.  Although, the 
number of bands was the same for both control and case, 
the bands size differed. Control samples had larger 
product size than case samples, so they migrated slower 
as opposed to the case samples. The same findings were 
observed  by  using  all  primers in which control samples 
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Figure 2. Agarose gel electrophoresis showing the product from real-time HRMA PCR for 
five primers amplifying PKD1 and PKD2 genes. The PCR products sizes were as expected. 
A, AC2.5, 120 bp; B, D16S291, 180 bp; C, D4S423, 120 bp; D, D4S1544, 250 bp; E, 




produced slightly larger bands than the case samples. 
PCR SSCP lies on the principle that when DNA is in a 
solution, they take secondary and tertiary conformations. 
The conformations are based on how the base pairing 
occur, depending upon the strand length, sequence and 
the location, and number of regions of base pairing 
(Gasser et al., 2006), as well as the primary sequence 
(Gasser and Chilton, 2001). Once electrophorized on a 
non-denaturing agar, the single-stranded DNA difference 
even in single nucleotides is distinguishable because of 
the mobility difference.       
 
 
DNA amplification in real-time PCR 
 
The DNA amplifications of all primers were satisfactory. 
However, there were differences between DNA from 
patients and control. Amplification of the control DNA 
started earlier than samples, although the samples were 
treated in the same manner and the quality and quantity 
of DNA after extraction were overall the same with no 
significant differences. Most amplification of control 
started in between 25 and 30 cycles, whereas for 
patients’ samples, the amplification started in between 30 
and 35 cycles. Even so, the PCR amplified products were 
analyzed in 1.5% agarose gel electrophoresis to show 
the presence of a single PCR product with the expected 
size (Figure 2). 
Amplification of DNA is crucial in real-time PCR. From 
our experience, samples that amplified much later (after 
35 cycles of a 40 cycles) will not give a good melting 
profile. This sample resembles ‘outlier’ in the melting 
graph that can either result in a false positive or a false 
negative result. Kristensen and Dobrovic (2008) found 
that outliers are the result from reactions that remain in 
the exponential phase or amplified very late and 
recommended them not to be included in analysis. To 
overcome such problem, we suggested a thorough 
assessment of DNA quality and specially prepared PCR 
reaction so that, the amplification can start earlier, 





Apparent melting curve graphs for control and case 
subjects were seen in five primers. Control samples 
melted at higher temperature than the case samples so 
that the melting curve profiles were shifted to the right. 
Case samples melted at a lower temperature and the 
melting curve profiles were shifted to the left. The mean 
melting temperature differences among control and case 
was 0.58°C. One primer had two melting domains, 
evidence in both control and case samples. 
Figure 3 shows five primers with apparent melting 
curves profiles. Primers AC2.5, D16S291 and D4S423 
had melting temperature difference of 0.5°C. Primer 
D4S1544 had a 0.8°C melting temperature difference, 
while primer D4S2460 had the slightest temperature 
difference by only 0.4°C. In all primers, control samples 
had higher melting temperature as compared to case 
samples. All control samples were shifted to the right, 
whereas case samples were shifted to the left. However, 
the melting curve pattern for control and case samples 
was the same. Judging from the melting curve pattern, 
control and case samples were possibly homozygote. 
The higher temperature needed for the control samples 
to  be  melted  suggested  that  the sequences had higher  
  































Figure 3. Normalized graphs showing apparent melting curves for primers amplifying the PKD genes. All 
control samples were shifted to the right whereas the case samples were all shifted to the left. A, Primer AC2.5. 
Controls were melted at 76.5°C, while case at 76.0°C. B, Primer D4S2460. Controls were melted at 78.4°C, 
and 0.4°C later to that of case samples. C, Primer D4S423. Controls were melted at 78.0°C, while case 
samples were at 77.5°C. D, Primer D4S1544. Control samples were melted at 0.8°C later case samples at 





guanine-cytosine (GC) contents that bind stronger than 
sequence with more adenosine-thymine (AT) contents. 
Apparent melting curve graphs of control and case 
sample  enables  them  to  be  differentiated according  to 
the HRMA profiles alone.  
Primer FF that amplified PKD1 gene had two melting 
domains (Figure 4). Both control and case samples were 
melted    two   times   at   72.2   and   73.0   and   73.1°C,
  












respectively. Interestingly, control and case samples 
melting profiles were ‘crosslinked’ at 73.4°C. The shifting 
of the melting profiles occurred here where control 
melting curve profile which was initially shifted to the right 
were shifted to the left and vice versa for the case 
samples melting curve profile. For HRMA, the sensitivity 
and reliability of the method decreases when amplicon 
size is more than 400 bp (Reed and Wittwer, 2004). As 
shown in Table 1, the product size of primer FF was 487 
bp. This might be the reason for the presence of two 
melting domains as well as the large percentage of GC in 
products. With higher GC content, mutation detections 
became more difficult as the presence of more than one 
melting domain might hinder the mutations, if present 
(Krypuy et al., 2007). Moreover, the temperature 
difference between the control and case samples melting 
curves were very small, making samples recognition and 
differentiation based on the HRMA profile alone difficult. 
We used the same primers for both PCR-SSCP and 
real-time HRM analysis. We found that by using common 
existing primers to amplify the PKD genes in real-time 
HRM analysis, the results were comparable to PCR-
SSCP, but with more advantages. Common primers can 
be used in real-time HRMA with addition of saturating 
dyes so that fluorescence signals are emitted and can be 
detected by the machine. New primers developments for 
ADPKD are not crucial for HRMA applications, as well as 
the need to label them with commercially available 
probes. The saturating dyes added to the PCR mix are 
more cost effective when used with real-time 
instrumentation as compared to probe-labelled system 
such as molecular beacons (Monis et al., 2005). Thus, 
the real-time HRMA does not only provide fast and 
reliable results, but it can be applied to a medium or large 
number of samples (Monis et al., 2005; Krypuy et al., 
2006) and is cost effective.  
PCR-SSCP method as well as real-time HRMA is 
capable to differentiate mix samples of control and 
ADPKD samples. However, PCR-SSCP is more 
laborious to complete and at least, two steps are required 
as compared to HRMA which is a single step procedure. 
No post PCR manipulations are needed in HRMA, 
including the need of post-PCR reagents additions, 
separations or purifications (Gundry et al., 2003; Millat et 
al., 2009a; Millat et al., 2009b), thus it reduces chances 
of mishandling and human errors (Kristensen and 
Dobrovic, 2008), as well as reducing the risk of PCR 
carryover   contamination   (Pornprasert et al., 2008)  and  
  




















Figure 4. A) Normalized graph for primer FF showing two melting domains for both control and case samples 







the crossover of PCR products (Krypuy et al., 2006). 
Therefore, this will increase the sensitivity for a more 
accurate amplicons differentiation. 
More time is needed for the PCR-SSCP procedure. 
The electrophoresis run time is based on the PCR 
product size. The larger the size, the longer the time 
needed for electrophoresis. We found that the method 
needs up to 18 h to be completed, until analysis can be 
done, whereas real-time HRMA needs at most 4 h to be 
completed and analysis can be done almost immediately 
after amplification. Results are obtained in a very short 
time. The rapidness of the method makes it appropriate 
to be applied to medium and large number of samples 
(Monis et al., 2005; Krypuy et al., 2006).  
We concluded that HRMA is an efficient method to 
differentiate ADPKD samples from control. HRMA is an 
inexpensive method which can be done in a single-step 
closed-tube procedure performed without gel 
electrophoresis. The samples can be kept at -20°C for 
further manipulations and agarose gel electrophoresis 
method can be used for analysis when the HRMA 
revealed unclear melting profile or for sequencing 
purpose as the method is non-destructive (Vossen et al., 
2009). The main limitation of HRM is that a specific 
mutation cannot be readily identified and it has to be 
combined with a sequencing method. Although, the 
samples used were less in number, the primers that were 
used in conventional PCR to detect mutations of the PKD 
genes can be applied in a HRMA to differentiate between 
control and ADPKD patients for a rapid screening 
process. It is a fast and reliable method and can replace 
the current methodology in screening the polymorphisms 
for ADPKD such as the PCR-SSCP technique. We 
applied this method with larger number of samples in 
screening the polymorphisms for congenital heart 
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